| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/10/2008 | US20080085301 Method for transdermal administration of antimicrobial medications |
| 04/10/2008 | US20080085296 Methods for reduction of post operative ileus. |
| 04/10/2008 | US20080085289 An immunogenic composition comprising Staphylococcal poly-N-acetylglucosamine (PNAG) and Type 8 capsular polysaccharide or oligosaccharide from Staph aureus; vaccines; e.g., mixture of a Staph extracellular component binding protein and a staph transporter protein, regulator of virulence or toxin |
| 04/10/2008 | US20080085284 Construction of a Comparative Database and Identification of Virulence Factors Comparison of Polymorphic Regions in Clinical Isolates of Infectious Organisms |
| 04/10/2008 | US20080085282 Methods of detecting and controlling mucoid pseudomonas biofilm production |
| 04/10/2008 | US20080085279 Murine double mutant binding protein (MTBP) inhibitor for use as tool in treatment and prevention of cell proliferative disorders |
| 04/10/2008 | US20080085278 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 04/10/2008 | US20080085272 Encapsulating therapeutic agent in spider silk fibroin; contolling release of pharmaceutical agents |
| 04/10/2008 | US20080085270 Mixture comprising g-gamma tocopherol, tocotrienol, black pepper extract and ubiquinone for use in treatment of cardiovascular disorders |
| 04/10/2008 | US20080085263 Liquid Depot Formulations |
| 04/10/2008 | US20080085261 Vaccine Adjuvant |
| 04/10/2008 | US20080085259 Amine condensation polymers as phosphate sequestrants |
| 04/10/2008 | US20080085257 Composition and method for topical treatment of skin conditions |
| 04/10/2008 | US20080085247 Composition of Menthyl Lactate and a Mixture of Menthol Isomers |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/10/2008 | US20080085243 Molecular markers for determining taxane responsiveness |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | US20080085239 complex with radioisotope; anticancer radiopharmaceutical; diagnosis of tumors |
| 04/10/2008 | DE19541815B4 Verwendung einer Lösung von Polyethylenglykol in Wasser als wässrige Spüllösung zur Prävention oder Behandlung von zähem Schleim, der in Verbindung mit Strahlen- oder/und Chemotherapie-induzierten Erkrankungen der Schleimhäute auftritt Using a solution of polyethylene glycol in water as an aqueous rinse solution for the prevention or treatment of thick mucus that occurs in conjunction with radiotherapy and / or chemotherapy-induced disorders of the mucous membranes |
| 04/10/2008 | DE112006001234T5 Verfahren und Zusammensetzung zur Behandlung von ARG A method and composition for the treatment of ARG |
| 04/10/2008 | DE112004001520B4 Verwendung eines Lipidglyzerids festgelegter Struktur zur Herstellung eines Medikamentes zur Behandlung der multiplen Sklerose Use of a Lipidglyzerids fixed structure for producing a medicament for the treatment of multiple sclerosis |
| 04/10/2008 | DE102006048130A1 Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil Transdermal therapeutic system with two-phase release profile |
| 04/10/2008 | DE102006047231A1 Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika Substituted indeno [1,2-b] indole derivatives as new inhibitors of protein kinase CK2 and their use as antitumor agents, cytostatic agents and diagnostic agents |
| 04/10/2008 | DE10066235B4 Targeted inhibition of gene expression by administration of double stranded oligoribonucleotide to a cell, useful for treating humans, animals and plants against viral infection |
| 04/10/2008 | CA2848238A1 Lipid containing formulations |
| 04/10/2008 | CA2667668A1 Amorphous asenapine and processes for preparing same |
| 04/10/2008 | CA2667082A1 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 04/10/2008 | CA2665490A1 Method for treatment of macular degeneration |
| 04/10/2008 | CA2665468A1 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids |
| 04/10/2008 | CA2665438A1 Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors |
| 04/10/2008 | CA2665435A1 Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 04/10/2008 | CA2665428A1 Hdac inhibitors |
| 04/10/2008 | CA2665403A1 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof |
| 04/10/2008 | CA2665398A1 Indazolyl derivatives useful as potassium channel modulating agents |
| 04/10/2008 | CA2665392A1 Anticoagulant compounds |
| 04/10/2008 | CA2665385A1 Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists |
| 04/10/2008 | CA2665380A1 Treatment of insulin resistance and disorders associated therewith |
| 04/10/2008 | CA2665349A1 Particle formation |
| 04/10/2008 | CA2665347A1 Process for the preparation of pleuromutilins |
| 04/10/2008 | CA2665225A1 Lipid containing formulations |
| 04/10/2008 | CA2665202A1 Compounds and methods |
| 04/10/2008 | CA2665141A1 Composition comprising crustacean gastrolith components and its use |
| 04/10/2008 | CA2665105A1 Injectable depot composition and its' process of preparation |
| 04/10/2008 | CA2665083A1 Mglur5 modulators |
| 04/10/2008 | CA2665037A1 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 04/10/2008 | CA2664986A1 Non-mucoadhesive film dosage forms |
| 04/10/2008 | CA2664985A1 Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism |
| 04/10/2008 | CA2664959A1 Use of chlorine guanabenz derivatives for treating prion-based diseases |
| 04/10/2008 | CA2664933A1 Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases |
| 04/10/2008 | CA2664878A1 Di-fluoro containing compounds as cysteine protease inhibitors |
| 04/10/2008 | CA2664852A1 High-molecular weight conjugate of resorcinol derivatives |
| 04/10/2008 | CA2664800A1 Ketoconazole enantiomer in humans |
| 04/10/2008 | CA2664790A1 Methods and ophthalmic devices used in the treatment of ocular allergies |
| 04/10/2008 | CA2664743A1 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative |
| 04/10/2008 | CA2664702A1 Mixed orl1/mu-agonists for the treatment of pain |
| 04/10/2008 | CA2664700A1 Silicon derivatives for pet imaging |
| 04/10/2008 | CA2664697A1 Methods, kits, and compositions for generating new hair follicles and growing hair |
| 04/10/2008 | CA2664688A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 04/10/2008 | CA2664673A1 Azithromycin for the treatment of nodular acne |
| 04/10/2008 | CA2664641A1 Controlled release dosage form of tacrolimus |
| 04/10/2008 | CA2664621A1 Pyrazine-2-carboxamide derivatives |
| 04/10/2008 | CA2664413A1 Treatment for non-alcoholic-steatohepatitis |
| 04/10/2008 | CA2664398A1 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/10/2008 | CA2664396A1 Enantiomerically pure phosphoindoles as hiv inhibitors |
| 04/10/2008 | CA2664380A1 Medicinal package |
| 04/10/2008 | CA2664158A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 04/10/2008 | CA2664119A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents |
| 04/10/2008 | CA2664004A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 04/10/2008 | CA2663856A1 Jak-2 modulators and methods of use |
| 04/10/2008 | CA2663817A1 Self-preserved aqueous pharmaceutical compositions |
| 04/10/2008 | CA2663614A1 Amine base salts of saha and polymorphs thereof |
| 04/10/2008 | CA2663436A1 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| 04/10/2008 | CA2663361A1 Methods for myocardial imaging in patients having a history of pulmonary disease |
| 04/10/2008 | CA2655139A1 Epoxide inhibitors of cysteine proteases |
| 04/10/2008 | CA2642455A1 Substituted 4-phenyl piperidines for use as renin inhibitors |
| 04/10/2008 | CA2564154A1 Immunocan |
| 04/09/2008 | EP1908850A1 Target for therapy of cognitive impairment |
| 04/09/2008 | EP1908834A2 Heteromultimeric ion channel receptor and uses thereof |
| 04/09/2008 | EP1908833A1 Novel temporal gene and application of the same |
| 04/09/2008 | EP1908768A1 Anticoagulant compounds |
| 04/09/2008 | EP1908765A1 Thienopyrimidine derivative |
| 04/09/2008 | EP1908764A1 Azolo triazines and pyrimidines |
| 04/09/2008 | EP1908762A2 Organic compounds |
| 04/09/2008 | EP1908761A1 Organic compounds |
| 04/09/2008 | EP1908760A1 Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation |
| 04/09/2008 | EP1908759A2 3,4-dihydro-3-amino-2H-1-benzopyrane and -benzothiopyrane derivatives as dopamine-beta-hydroxylase Inhibitors and methods of their preparation |
| 04/09/2008 | EP1908757A1 Choline salt crystal of azulene compound |
| 04/09/2008 | EP1908755A1 Therapeutic agent for restenosis |
| 04/09/2008 | EP1908754A1 Antibiotic maduraphthalazin salts with delayed release of the active substance and their use |
| 04/09/2008 | EP1908753A1 Novel heterocyclidene acetamide derivative |
| 04/09/2008 | EP1908752A1 Novel 2-quinolone derivative |
| 04/09/2008 | EP1908751A1 N-hydroxy benzamides with antitumour activity |
| 04/09/2008 | EP1908750A1 Process for the preparation of pleuromutilins |
| 04/09/2008 | EP1908492A1 Metabotropic glutamate receptor activator |
| 04/09/2008 | EP1908481A1 Agent for reduction of bleeding in cerebrovascular disorder |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1908477A2 Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| 04/09/2008 | EP1908476A1 Galectin-2 for the treatment of inflammatory diseases of the skin |
| 04/09/2008 | EP1908475A1 Use of anti-prolactin agents to treat cancer |
| 04/09/2008 | EP1908473A1 Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli |